(Bloomberg) -- Health and Human Services Secretary Robert F. Kennedy Jr. defended cutting thousands of staff while attacking the agency’s past work in one of his first appearances before Congress since taking office. Most Read from Bloomberg As Coastline Erodes, One California City Considers ‘Retreat Now’ A New Central Park Amenity, Tailored to Its East Harlem Neighbors Power-Hungry Data Centers Are Warming Homes in the Nordics How a Highway Became San Francisco’s Newest Park In exchanges with lawmakers that at times became tense, Kennedy told the House Appropriations Committee Wednesday that the cuts made progress toward President Donald Trump’s goal to shrink federal spending. He also said the focus of the agency had turned to disease prevention rather than treatment, framing past efforts on addressing existing diseases instead of stopping them as evidence of corruption. In particular, he said there has been research on treatments for colorectal cancer at the National Institutes of Health, but not research on why rates are rising in children. “No research was done on it. The etiology of all these chronic diseases were just buried because they didn’t want to offend the large industries who are putting poisons in our food and putting them in our pharmaceutical products,” Kennedy said. Kennedy was pressed on the workforce reductions, which amounted to about 20% of staff with the inclusion of workers who voluntarily left and took buyouts or early retirement packages. In one instance, he doubled down on cuts to employees who ran a heating assistance program for low-income people and said he has the power to reverse firings. While Kennedy characterizes the cuts as a bid to streamline redundancies, the agency has also laid off employees conducting research in food safety labs, running firefighter health programs, working to make infant formula safer and studying childhood lead exposure. In response to questions from House Democrats about whether he is spending money that Congress allocated for specific causes, Kennedy said he will follow the law and spend money if lawmakers designate it for a certain program. The Trump administration is asking for $94 billion for HHS and its sub-agencies — $33 billion less than last year — according to budget documents released earlier this month. The biggest cuts are focused on the NIH and Centers for Disease Control and Prevention. Trump Objectives Kennedy, who will also testify on his agency’s 2026 budget request in front of the Senate Health, Education, Labor and Pensions Committee on Wednesday, is planning to use the budget as a tool to pursue his so-called Make America Healthy Again agenda. Story Continues That means including funding for chronic disease prevention, protection from environmental toxins, nutrition, food and drug safety, and services for American Indians and Alaska Natives. Also included are programs that push what he calls healthy lifestyles, over-reliance on medication and treatments and the effects of new technological habits, according to prepared remarks seen by Bloomberg. Kennedy told the Appropriations Committee new dietary guidelines will be released potentially “before August” that will focus more on unprocessed foods. In addition to aligning the budget with Trump’s goals, Kennedy touted work he’d done to boost US drug manufacturing — one of the president’s longtime objectives. Kennedy spoke positively about his relationships with companies that make food and pharmaceuticals, and mentioned he’s met repeatedly with Eli Lilly & Co. and other drugmakers about domestic drug manufacturing. He’s also gone after topics that frequently draw Trump’s ire, like diversity, equity and inclusion initiatives. “Americans do not want their tax dollars going to initiatives that espouse radical ideologies,” Kennedy said in his prepared remarks. “We are committed to restoring a tradition of gold-standard, evidence-based science — not one driven by politicized DEI, gender ideology, nor sexual identity.” The topic was the subject of a particularly charged back-and-forth between Kennedy and Democratic Representative Bonnie Watson Coleman. The Congresswoman grilled Kennedy about why the agency was targeting grants with language like “Black,” “race,” “bias” and “oppression.” Kennedy said Trump is “deeply concerned” about disproportionately bad outcomes in maternal health for Black mothers and wants a “color blind” administration. “I don’t need this rhetoric about Donald Trump and the lie that he cares about me or Black people,” she replied. (Updates details throughout.) Most Read from Bloomberg Businessweek Cartoon Network’s Last Gasp DeepSeek’s ‘Tech Madman’ Founder Is Threatening US Dominance in AI Race Why Obesity Drugs Are Getting Cheaper — and Also More Expensive Trump Has Already Ruined Christmas The Recession Chatter Is Getting Louder. Watch These Metrics ©2025 Bloomberg L.P. View Comments
RFK Jr. Attacks Health Agency, Defends Cuts Before Congress
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...